Cumberland Pharmaceutical... (CPIX)
NASDAQ: CPIX
· Real-Time Price · USD
3.36
-0.09 (-2.61%)
At close: Oct 13, 2025, 3:59 PM
3.33
-0.89%
After-hours: Oct 13, 2025, 04:24 PM EDT
-2.61% (1D)
| Bid | 2.5 |
| Market Cap | 50.27M |
| Revenue (ttm) | 42.07M |
| Net Income (ttm) | -2.93M |
| EPS (ttm) | -0.22 |
| PE Ratio (ttm) | -15.27 |
| Forward PE | -6.27 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 4.35 |
| Volume | 21,880 |
| Avg. Volume (20D) | 53,820 |
| Open | 3.51 |
| Previous Close | 3.45 |
| Day's Range | 3.33 - 3.56 |
| 52-Week Range | 1.04 - 7.25 |
| Beta | -0.41 |
| Ex-Dividend Date | n/a |
About CPIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CPIX
Website n/a
2 months ago
+13.92%
Cumberland Pharmaceuticals shares are trading high...
Unlock content with
Pro Subscription
4 months ago
+9.36%
Cumberland Pharmaceuticals shares are trading higher after the company announced it published a study investigating Caldolor in older patients.
2 months ago · seekingalpha.com
Cumberland Pharmaceuticals Inc. (CPIX) Q2 2025 Earnings Call TranscriptCumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants A. J. Kazimi - Founder, Chairman, President & CEO John Michael Hamm - VP ...